Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat administration of tadalafil after curative treatment for hepatocellular carcinoma (Phase 1/2)
KCT0003946Phase 2Recruiting
- Sponsor
- Daewoong Pharmaceutical
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in hepatocellular carcinoma (HCC), sponsored by Daewoong Pharmaceutical. Started May 2019; status: recruiting.
02
Drugs
tadalafil
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on KCT0003946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003946.